Therapeutical Impact of a Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly

Assistance Publique - Hôpitaux de Paris1 site in 1 country260 target enrollmentNovember 2004

ConditionsMyocardial Ischemia

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Myocardial Ischemia
Sponsor: Assistance Publique - Hôpitaux de Paris
Enrollment: 260
Locations: 1
Primary Endpoint: therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly
Status: Terminated
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment.

in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.

Detailed Description

not desired

Registry

clinicaltrials.gov

Start Date

November 2004

End Date

November 2006

Last Updated

10 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Assistance Publique - Hôpitaux de Paris

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•patients 75 of age or older hospitalized in a geriatric service and suspect of coronary heart disease

Exclusion Criteria

•acute myocardial infarction

Outcomes

Primary Outcomes

therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly

Time Frame: during hospitalization

Secondary Outcomes

part link, in the treatment modification, with diagnosis reassessment and the part link with treatment optimization, death and rehospitalization in the subsequent 6 and 12 months(during hospitalization)